Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Copy neutral loss of heterozygosity is more frequent in older ovarian cancer patients

Published:2013-05-28 Issue:9 Volume:52 Page:794-801
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Pedersen Brent S.¹,Konstantinopoulos Panagiotis A.²,Spillman Monique A.¹³,De Subhajyoti¹⁴

Affiliation:

1. Department of Medicine; University of Colorado School of Medicine; Aurora CO

2. Department of Medical Oncology; Dana-Farber Cancer Institute, Harvard Medical School; Boston MA

3. Department of Obstetrics & Gynecology; University of Colorado School of Medicine; Aurora CO

4. Molecular Oncology program, University of Colorado Cancer Center; Aurora CO

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22075/fullpdf

Reference34 articles.

1. Increased cell-to-cell variation in gene expression in ageing mouse heart;Bahar;Nature,2006

2. Antineoplastic chemotherapy of the older cancer patient;Balducci;Hematol Oncol Clin North Am,2000

3. Does age influence loss of heterozygosity?;Carr;Exp Gerontol,2008

4. Playing the end game: DNA double-strand break repair pathway choice;Chapman;Mol Cell,2012

5. DNA damage, cellular senescence and organismal ageing;Chen;Causal or correlative? Nucleic Acids Res,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials;Expert Review of Anticancer Therapy;2024-01-25

2. Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?;Seminars in Cancer Biology;2021-12

3. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma;International Journal of Gynecological Pathology;2021-02-09

4. Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials;Critical Reviews in Oncology/Hematology;2021-01

5. Germline copy number variations are associated with breast cancer risk and prognosis;Scientific Reports;2017-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3